Professor | Yonsei University College of Medicine | South Korea
Dr. Tae Il Kim is a distinguished researcher at Yonsei University College of Medicine in Seoul, South Korea, specializing in gastroenterology, colorectal cancer, and precision oncology. He has authored 337 Documents, which have received 8,659 citations, and holds an h-index of 46, reflecting his substantial global impact in biomedical and clinical research. Dr. Kim’s work focuses on translational and clinical studies that advance the understanding, diagnosis, and treatment of colorectal cancer and related gastrointestinal disorders. His notable contributions include elucidation of the HER2-ELF3-KRAS signaling axis in KRASG13D colorectal cancer, development of a novel risk score for 30-day adverse events following colonoscopy in older adults, and identification of circulating RNA biomarkers associated with the adenoma–carcinoma sequence. He has also pioneered multi-omic and machine learning-based approaches for precision oncology, including the CAN-Scan platform and non-invasive screening tools for early detection, as well as genome-wide association studies on nonhereditary colorectal polyposis and its recurrence. Dr. Kim collaborates extensively with over 800 co-authors across diverse disciplines and institutions, demonstrating a commitment to interdisciplinary and international research networks. His work has significantly contributed to improved patient care, early diagnosis, personalized therapeutic strategies, and the translation of scientific discoveries into clinical practice. By integrating innovation, rigorous research, and collaboration, Dr. Kim continues to shape the future of gastroenterology and oncology, enhancing global knowledge, advancing precision medicine, and elevating the visibility of Korean medical research on the international stage, with a tangible societal impact through better patient outcomes and public health advancements.
Profiles: Scopus | ORCID
Featured Publications
Kim, T. I., et al. (2025). Differential cellular origins of the extracellular matrix of tumor and normal tissues according to colorectal cancer subtypes: Cellular and Molecular Biology. British Journal of Cancer. (Citations: 3)
Kim, T. I., et al. (2025). Circulating RNA markers associated with adenoma–carcinoma sequence in colorectal cancer. International Journal of Molecular Sciences. (Citations: 3)
Kim, T. I., et al. (2025). CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer. Cell Reports Medicine. (Citations: 2)
Kim, T. I., et al. (2025). Machine learning-enabled non-invasive screening of tumor-associated circulating transcripts for early detection of colorectal cancer. International Journal of Molecular Sciences. (Citations: 2)
Kim, T. I., et al. (2025). Identification of genetic factors related with nonhereditary colorectal polyposis and its recurrence through genome-wide association study. Journal of Gastroenterology and Hepatology Australia.(Citations: 1)
